Physician profile
Michael T Mcgrath
NPI 1942439013
$3,323.67
in general payments reported to CMS, 2019-2025
17 companies · $714 in 2025
The $714 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $267 · 2021: $710 · 2022: $505 · 2023: $344 · 2024: $450 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,363.76 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $408.61 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $284.91 | 2019-2025 | |
| Glaukos Corporation | $254.04 | 2022-2025 | Idosetr |
| Coopervision INC. | $203.60 | 2019-2025 | Clariti Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Allergan, INC. | $192.79 | 2019-2022 | |
| Lkc Technologies, INC. | $90.46 | 2024 | |
| Biotissue Holdings INC. | $86.37 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $82.74 | 2023-2025 | Miebo, Infuse, Biotrue One Day |
| Abbvie INC. | $66.55 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.38 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $49.15 | 2022-2023 | Cequa |
| Oyster Point Pharma, INC. | $48.44 | 2022-2024 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $46.51 | 2021-2022 | |
| Shire North American Group INC | $32.19 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $28.77 | 2021-2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.